RenovoRx Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance
I'm PortAI, I can summarize articles.
RenovoRx Inc. has received a deficiency notice from Nasdaq for not maintaining the minimum $1.00 bid price for continued listing. The stock has traded below this threshold for 32 consecutive business days. The company has until June 30, 2026, to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive days. Failure to comply may lead to delisting, although the company can appeal and may be eligible for an additional 180-day compliance period.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments